Eagle Genomics Gains Microsoft Co-Sell Status for Microbiome Mapping AI Platform
Crescendo Biologics Strenghthens its Management team
Using Public Money to Leverage Private Finance into our Portfolio
We have leveraged £200+ million of private investment to create more than 40 companies.
Astellas Announces Acquisition of Quethera
UKI2S announces seed investment in Cagen
CellCentric raises $26m for new late-state prostate cancer drug
To discuss a requirement or obtain further information please feel free to contact us.
Midven Limited Cavendish House 39-41 Waterloo Street Birmingham B2 5PP Telephone: 0121 710 1990 Fax: 0121 710 1999 Email: enquiries@UKI2S.co.uk
c/o STFC Innovations Ltd. Harwell, Oxford OX11 0QX
